William B. Fisher

Phase III Study of Cisplatin, Etoposide, and Concurrent Chest Radiation With or Without Consolidation Docetaxel in Patients With Inoperable Stage III Non–Small-Cell Lung Cancer: The Hoosier Oncology Group and U.S. Oncology

Nasser H. Hanna, Marcus A. Neubauer, Constantin T. Yiannoutsos et al. · Journal of Clinical Oncology · 2008 · 492 citations

Cisplatin plus etoposide with and without ifosfamide in extensive small-cell lung cancer: a Hoosier Oncology Group study.

Patrick J. Loehrer, Rafat Ansari, R Gonin et al. · Journal of Clinical Oncology · 1995 · 154 citations

Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small-cell lung cancer: a Hoosier Oncology Group protocol.

Charles D. Blanke, Rafat Ansari, R. Mantravadi et al. · Journal of Clinical Oncology · 1995 · 145 citations

Random prospective study of vindesine versus vindesine plus high-dose cisplatin versus vindesine plus cisplatin plus mitomycin C in advanced non-small-cell lung cancer.

L H Einhorn, Patrick J. Loehrer, Stephen D. Williams et al. · Journal of Clinical Oncology · 1986 · 127 citations

Random Prospective Study, Mitomycin C, Medicine +14

Updated survival and outcomes for older adults with inoperable stage III non-small-cell lung cancer treated with cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel: analysis of a phase III trial from the Hoosier Oncology Group (HOG) and US Oncology

Shadia I. Jalal, Heather Riggs, A. Melnyk et al. · Annals of Oncology · 2011 · 79 citations · Full text

Radiation Medicine, Hoosier Oncology Group, Medicine +11